PIM
JAZZ icon

Plato Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Plato Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,895
Closed -$202K – 558
2024
Q2 		$202K Hold
1,895
– – 0.02% 332
2024
Q1 		$228K Buy
+1,895
New +$232K 0.02% 312

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Plato Investment Management's JAZZ Position: Q3 2024 in Review

Plato Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2024, closing a stake of 1,895 shares — an estimated $202K sold.

Plato Investment Management first reported a position in JAZZ in Q1 2024 and held it in 2 quarters. The position peaked at $228K in Q1 2024. 477 funds tracked by Wall St. Rank hold JAZZ as of Q3 2024.

  • Plato Investment Management reported no remaining Jazz Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Plato Investment Management sold 1,895 Jazz Pharmaceuticals shares in Q3 2024, an estimated $202K.
  • Plato Investment Management first reported a position in Jazz Pharmaceuticals in Q1 2024 and held it in 2 quarters.
  • Plato Investment Management's Jazz Pharmaceuticals position peaked at $228K in Q1 2024.
  • 477 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2024.

Based on Plato Investment Management's 13F filing for Q3 2024, filed 6 Nov 2024.